Company
Azura Ophthalmics
Developing first-in-class ophthalmic keratolytics the first Pharmaceutical for the Treatment of Meibomian Gland Dysfunction
Also known as Azura, Azura Ophthalmics Pty Ltd
- Business model
- B2B
- Founded
- 2014
- Legal name
- Azura Ophthalmics Pty Ltd
- azuraophthalmics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Developing first-in-class ophthalmic keratolytics the first Pharmaceutical for the Treatment of Meibomian Gland Dysfunction
Funding snapshot
- Total raised
- $20MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Grant2022-09-07
Funding rounds
- Grant
- 2022-09-07
- Round, 2020
- $20M2020-10-22, Company stated
- Series B
- 2017-10-10
Products
- Other
- AZR-MD-001
- Web
- AZR-MD-001
Loading relationship preview